{"id":"clemastin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Angle-closure glaucoma","Benign prostatic hyperplasia","Bladder outflow obstruction","Chronic idiopathic constipation","Hypertensive disorder","Hyperthyroidism","Ocular hypertension","Peptic ulcer","Retention of urine"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"60848a1b-f999-43d5-9df9-548f2f508401","title":"CLEMASTINE FUMARATE POWDER [AX PHARMACEUTICAL CORP]"},"ecosystem":[],"mechanism":{"target":"5-hydroxytryptamine receptor 6, Cytochrome P450 2C19, Solute carrier family 22 member 1"},"_scrapedAt":"2026-03-28T01:06:18.260Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Allergic conjunctivitis","diseaseId":"allergic-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anaphylaxis Adjunct","diseaseId":"anaphylaxis-adjunct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dermatographic urticaria","diseaseId":"dermatographic-urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Itching of skin","diseaseId":"itching-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nasal congestion","diseaseId":"nasal-congestion","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nasal discharge","diseaseId":"nasal-discharge","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sneezing","diseaseId":"sneezing","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urticaria","diseaseId":"urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vasomotor rhinitis","diseaseId":"vasomotor-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01843530","phase":"PHASE3","title":"Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2013-11","conditions":"Acute ACE-induced Angioedema","enrollment":31},{"nctId":"NCT02364453","phase":"NA","title":"The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients","status":"COMPLETED","sponsor":"Song Guo","startDate":"2015-02","conditions":"Migraine Without Aura","enrollment":20},{"nctId":"NCT01154361","phase":"PHASE2","title":"AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"","conditions":"Angioedema","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":34,"reaction":"DYSPNOEA"},{"count":30,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":28,"reaction":"ERYTHEMA"},{"count":28,"reaction":"PYREXIA"},{"count":23,"reaction":"ANAEMIA"},{"count":20,"reaction":"OFF LABEL USE"},{"count":18,"reaction":"NAUSEA"},{"count":17,"reaction":"DIARRHOEA"},{"count":17,"reaction":"RASH"},{"count":15,"reaction":"CHILLS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":17,"therapeuticAreas":["Dermatology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Clemastin","genericName":"Clemastin","companyName":"Technical University of Munich","companyId":"technical-university-of-munich","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}